Kopczynski Casey C. 4
4 · AERIE PHARMACEUTICALS INC · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Kopczynski Casey C.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-15$0.20/sh+60,651$11,888→ 265,522 total - Tax Payment
Common Stock
2021-02-15$16.41/sh−725$11,897→ 264,797 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-15−60,651→ 0 totalExercise: $0.20Exp: 2021-04-28→ Common Stock (60,651 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable. If not exercised, the option would have expired on April 28, 2021.